Location: Home
  • search
  • go
  • WiCON News
    WiCON and major US investment firms seek M&A opportunities in the Chinese Pharma Industry 1/11/2006

    WiCON International Group has recently reached agreement with a number of major US investment firms to help them identify, screen and negotiate with potential M&A opportunities in the Chinese pharmaceutical industry.

    Ideal candidates should be profitable, have at least an annual sales of RMB 200 million, and need equity investment at and above US$20 million.

    Interested party please contact us at (010) 62354966 ext. 801 or e-mail: jshen@jicaipharma.com



  • Site map | Contact Us | Links
  • © Wicon International Group